Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Chipiron logo — Shaping the future of Healthcare by building the next-gen of...

Chipiron

Shaping the future of Healthcare by building the next-gen of MRI machines

Founded 2020 France France 50 employees Series A Total: $26.00M Health Care, Health and Wellness +2

General Information

Company Name Chipiron
Founded Year 2020
Location France France
Employees 50
Industries Health Care, Health and Wellness, Manufacturing +1
Funding Stage Series A
Business Model B2B
Revenue Model Product Sales, Leasing/Rental, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Chipiron. To contact Chipiron, visit chipiron.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Chipiron compare?

A PDF of Chipiron and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Chipiron soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Chipiron

Chipiron, founded in 2020 and headquartered in France, is pioneering advancements in the healthcare industry by developing next-generation MRI machines. With the compelling slogan, "Shaping the future of Healthcare by building the next-gen of MRI machines," Chipiron aims to empower wider community access to MRI technology.

The company is addressing a critical need by creating the first lightweight, cost-effective MRI machines capable of operating at ultra-low magnetic fields without sacrificing image quality. By making MRI technology 100 times more accessible, Chipiron aspires to transform healthcare through broader applications and earlier disease detection, potentially elevating MRI usage to be as routine as blood sampling.

Recently, Chipiron secured a €14.90M Series A investment on April 30, 2025, with funders including Unruly Capital, Blast, EIC Fund, iXcore, and Exor Ventures. This investment underscores strong investor confidence in Chipiron's mission and its potential impact on the healthcare landscape.

Business keywords: MRI Innovation, Quantum Detectors, Medical Imaging, Early Disease Detection, Diagnostic Equipment, Healthcare Accessibility, Medical Device Innovation, Healthcare Transformation, Quantum Technology, Portable MRI, Low-cost Healthcare Solutions

Services & Products

Developing scalable MRI technologies
Facilitating early cancer diagnosis
Enhancing MRI accessibility and affordability

Target Customers

Healthcare providers Hospitals and clinics Medical imaging centers Oncologists Radiologists

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €14.90M 5
Unruly Capital
Unruly Capital, Blast +3
30 Apr 2025
Grant €2.50M 2
France 2030, EIC Accelerator
15 Jul 2024
Grant €1.10M 1
Bpifrance
Bpifrance
01 Apr 2024
Seed Round $2.60M 2
Unruly Capital
Unruly Capital, Exor Ventures
20 Mar 2023
Grant $1.00M 2
Bpifrance
Bpifrance, Région Ile-de-France
01 Sep 2022
Seed Round $2.60M 2
Unruly Capital
Unruly Capital, Exor Ventures
01 Jan 2022
Pre Seed Round $1.20M 1
Entrepreneurs First
31 May 2021
Pre Seed Round $100.00K 1
Entrepreneur First
Entrepreneur First
07 Jul 2020

Latest News

View All
From eggs to avocados – Germany’s Orbem raises €55.5 million for AI-powered MRI expansion — Eu-startups
From eggs to avocados – Germany’s Orbem raises €55.5 million for AI-powered MRI expansion
Eu-startups Jan 20, 2026
The biggest European deeptech deals in H1 2025 — Tech
The biggest European deeptech deals in H1 2025
Tech Dec 18, 2025
From lab to market: 10 of the most promising EU-funded HealthTech startups — Eu-startups
From lab to market: 10 of the most promising EU-funded HealthTech startups
Eu-startups Aug 06, 2025
Chipiron raises $17M to launch portable MRI — Tech
Chipiron raises $17M to launch portable MRI
Tech Apr 30, 2025
French DeepTech Chipiron raises €14 million to “make MRIs as accessible as X-rays” — Eu-startups
French DeepTech Chipiron raises €14 million to “make MRIs as accessible as X-rays”
Eu-startups Apr 30, 2025

Chipiron Alternatives & Competitors

View All Alternatives
Chipiron vs
Cyted Health
Cyted Health United Kingdom

Transforming access to digestive health for everyone, everywhere.

Non Equity Assistance
74 employees
AI, Biotechnology
Compare Chipiron vs Cyted Health
Chipiron vs
Hyperfine | AI-Powered Portable MRI
Hyperfine | AI-Powered Portable MRI United States

The Swoop® system brings MR brain imaging within reach. Nasdaq: $HYPR

Grant
155 employees
Health Care, IT
Compare Chipiron vs Hyperfine | AI-Powered Portable MRI
Chipiron vs
Hexarad
Hexarad United Kingdom

The only end-to-end Radiology solution.

Growth
123 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Chipiron

Shaping the future of Healthcare by building the next-gen of MRI machines
Chipiron was founded in 2020.
Chipiron is headquartered in France.
Chipiron operates in Health Care, Health and Wellness, Manufacturing and Medical Devices. Its work centres on MRI Innovation, Quantum Detectors, Medical Imaging and Early Disease Detection. Its customers include Healthcare providers, Hospitals and clinics and Medical imaging centers.
Chipiron has a B2B business model. Its revenue comes from Product Sales, Leasing/Rental and Service Fee.
Chipiron has approximately 50 employees.
Chipiron has completed 8 funding rounds, raising a total of $26.00M. The latest funding stage is Series A.
Chipiron offers: Developing scalable MRI technologies, Facilitating early cancer diagnosis, Enhancing MRI accessibility and affordability.
Top alternatives and competitors to Chipiron include Cyted Health, Hyperfine | AI-Powered Portable MRI, Hexarad, Promaxo, Caption Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chipiron and Cyted Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chipiron, https://bouncewatch.com/company/chipiron, updated 24 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes